In this study, we investigated the effects of HGFK1 and Endostatin, the commonly used endogenous anti-angiogenesis molecule, on the CD90+ CSCs of HCC both in vitro and in vivo. This evidence concerns the gene THY1 and hepatocellular carcinoma.